GAPDH and colorectal cancer: Further downstream of PFKFB3 and FBP1, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is elevated in TECs in human colorectal cancer (CRC) tissue compared to adjacent tissue ECs, contributing to the dysregulated tumor blood vessel phenotype [32].